Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic targeted radionuclide therapy: potential new areas.

Jeffrey Y C Wong1

  • 1Division of Radiation Oncology and Radiation Research, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, USA. jwong@coh.org

International Journal of Radiation Oncology, Biology, Physics
|September 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2D or not 2D? For Total Body Irradiation, That Is the Question.

International journal of radiation oncology, biology, physics·2026
Same author

CD8 PET imaging with [<sup>89</sup>Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study.

Journal for immunotherapy of cancer·2026
Same author

A Prospective First-In-Human Pilot Study <sup>18</sup>F-DCFPyL Prostate-Specific Membrane Antigen Imaging on the RefleXion X1 Positron Emission Tomography-Computed Tomograpghy Subsystem in Patients with Prostate Cancer.

Advances in radiation oncology·2025
Same author

Combination Image-Guided and Antibody-Targeted α-Therapy Before Targeted Immunotherapy for Treatment of Solid Tumors.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

Rationale, implementation considerations, delineation and planning target objective recommendations for volumetric modulated arc therapy and helical tomotherapy total body irradiation, total marrow irradiation, total marrow and lymphoid irradiation and total lymphoid irradiation.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025
Same author

Evaluation of the Immunomodulatory Effects of Radiation for Chimeric Antigen Receptor T Cell Therapy in Glioblastoma Multiforme.

Cells·2024
Same journal

Highly Variable, Complex, and Contextual: The Business of Radiation Oncology Practice.

International journal of radiation oncology, biology, physics·2026
Same journal

Corrigendum to 'Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation' [International Journal of Radiation Oncology*Biology*Physics Volume 112, Issue 5, 1 April 2022, Pages 1243-1255].

International journal of radiation oncology, biology, physics·2026
Same journal

Multicenter external validation of normal tissue complication probability models for radiation-induced primary hypothyroidism in head and neck cancer survivors with long-term endocrine outcomes.

International journal of radiation oncology, biology, physics·2026
Same journal

THGEM-Based Air Ionization Chamber for Online Dose Monitoring in Conventional and FLASH Radiotherapy.

International journal of radiation oncology, biology, physics·2026
Same journal

Single Percussive Ventilation Breath-hold Imaging and Delivery in Lung Tumor Stereotactic Ablative Radiation Therapy: Initial Observations From a Prospective Clinical Trial.

International journal of radiation oncology, biology, physics·2026
Same journal

Proton beam therapy in nonmetastatic rhabdomyosarcoma: Outcome, prognostic factors and the effect of timing of radiation therapy.

International journal of radiation oncology, biology, physics·2026
See all related articles

Systemic targeted radionuclide therapy (STaRT) represents a new frontier in radiation oncology, offering biologically targeted treatments. STaRT shows promise, especially when combined with other therapies for minimal or micrometastatic disease.

Area of Science:

  • Oncology
  • Radiotherapy
  • Nuclear Medicine

Background:

  • Radiation oncology is advancing with novel, targeted therapeutic approaches.
  • External beam radiotherapy now utilizes advanced imaging for precise tumor targeting.
  • Systemic Targeted Radionuclide Therapy (STaRT) introduces biologically targeted radiation delivery.

Purpose of the Study:

  • To highlight the potential and advancements in Systemic Targeted Radionuclide Therapy (STaRT).
  • To discuss optimization strategies for enhancing STaRT efficacy.
  • To explore the role of STaRT within multimodality treatment regimens.

Main Methods:

  • Integration of functional and anatomic tumor imaging in external beam radiotherapy.
  • Development and application of antibody-targeted radiotherapy.

Related Experiment Videos

  • Strategies for improving STaRT delivery systems and tumor microenvironment modification.

    • Main Results:

    • FDA approval of two anti-CD20 radiolabeled antibodies demonstrates STaRT's clinical success.
    • Antibody-targeted radiotherapy shows impressive clinical results.
    • Optimization strategies are crucial for improving STaRT's effectiveness.

    Conclusions:

    • STaRT offers a significant advancement in radiation oncology, providing biologically targeted radiation.
    • Further optimization of STaRT delivery and tumor targeting is essential.
    • STaRT holds greatest potential as part of multimodality regimens, particularly for minimal or micrometastatic disease.